Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Intel
INTC
|
+$661M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$484M |
| 3 |
Amazon
AMZN
|
+$482M |
| 4 |
Netflix
NFLX
|
+$345M |
| 5 |
Pfizer
PFE
|
+$314M |
Top Sells
| 1 |
Apple
AAPL
|
+$900M |
| 2 |
Microsoft
MSFT
|
+$393M |
| 3 |
UnitedHealth
UNH
|
+$388M |
| 4 |
Merck
MRK
|
+$272M |
| 5 |
Bank of America
BAC
|
+$265M |
Sector Composition
| 1 | Technology | 22.26% |
| 2 | Healthcare | 14.77% |
| 3 | Financials | 12.79% |
| 4 | Consumer Discretionary | 10.52% |
| 5 | Communication Services | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Aprea Therapeutics
APRE
$9.03M
| $748K | ﹤0.01% |
1,076
+201
| +23% | +$140K |
|
|
CUTR
2627
DELISTED
Cutera, Inc.
CUTR
| $748K | ﹤0.01% |
57,325
-9,778
| -15% | -$128K |
|
2628
Astrana Health
ASTH
$1.4B
| $745K | ﹤0.01% |
57,700
+8,167
| +16% | +$105K |
|
|
AMRS
2629
DELISTED
Amyris Inc.
AMRS
| $745K | ﹤0.01% |
291,013
+100,454
| +53% | +$257K |
|
|
PZN
2630
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $744K | ﹤0.01% |
166,933
+1,378
| +0.8% | +$6.14K |
|
2631
First Internet Bancorp
INBK
$210M
| $741K | ﹤0.01% |
45,137
+2,913
| +7% | +$47.8K |
|
|
VIE
2632
DELISTED
Viela Bio, Inc. Common Stock
VIE
| $741K | ﹤0.01% |
19,495
+10,888
| +127% | +$414K |
|
2633
Greenlight Captial
GLRE
$431M
| $740K | ﹤0.01% |
124,471
-477
| -0.4% | -$2.84K |
|
|
OPTN
2634
DELISTED
OptiNose
OPTN
| $734K | ﹤0.01% |
10,897
+1,838
| +20% | +$124K |
|
2635
Napco Security Technologies
NSSC
$1.43B
| $732K | ﹤0.01% |
96,426
+4,326
| +5% | +$32.8K |
|
|
GRTS
2636
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $731K | ﹤0.01% |
125,568
+9,039
| +8% | +$52.6K |
|
2637
KKR & Co
KKR
$122B
| $728K | ﹤0.01% |
+31,012
| New | +$728K |
|
|
LL
2638
DELISTED
LL Flooring Holdings, Inc.
LL
| $727K | ﹤0.01% |
154,974
-623
| -0.4% | -$2.92K |
|
|
BBBY
2639
Bed Bath & Beyond, Inc.
BBBY
$638M
| $724K | ﹤0.01% |
159,667
-16,135
| -9% | -$73.2K |
|
2640
Safe Bulkers
SB
$462M
| $724K | ﹤0.01% |
608,910
+38,520
| +7% | +$45.8K |
|
|
CHMI
2641
Cherry Hill Mortgage Investment Corp
CHMI
$105M
| $721K | ﹤0.01% |
116,255
-58,039
| -33% | -$360K |
|
|
MCBC
2642
DELISTED
Macatawa Bank Corp
MCBC
| $721K | ﹤0.01% |
101,292
-32
| -0% | -$228 |
|
2643
Nathan's Famous
NATH
$431M
| $715K | ﹤0.01% |
11,722
+5,498
| +88% | +$335K |
|
|
STML
2644
DELISTED
Stemline Therapeutics, Inc.
STML
| $713K | ﹤0.01% |
147,252
-430
| -0.3% | -$2.08K |
|
|
DNR
2645
DELISTED
Denbury Resources, Inc.
DNR
| $708K | ﹤0.01% |
3,831,396
-138,839
| -3% | -$25.7K |
|
2646
Zynex
ZYXI
$45.4M
| $707K | ﹤0.01% |
70,283
-51,226
| -42% | -$515K |
|
2647
Hurco Companies Inc
HURC
$114M
| $706K | ﹤0.01% |
24,267
+11,410
| +89% | +$332K |
|
|
CNBKA
2648
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $704K | ﹤0.01% |
11,307
+5,172
| +84% | +$322K |
|
2649
Ocular Therapeutix
OCUL
$2.22B
| $701K | ﹤0.01% |
141,749
+8,261
| +6% | +$40.9K |
|
2650
Protagonist Therapeutics
PTGX
$3.63B
| $700K | ﹤0.01% |
99,073
-95,364
| -49% | -$674K |
|